Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07127705

Rapid Response of Stem Cells and Immune Cells for Efficacy

Rapid Response of Stem Cells and Immune Cells for Efficacy: An Acute Randomized Double-blind Placebo-controlled Cross-over Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Natural Immune Systems Inc · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.

Detailed description

This clinical trial aims at documenting acute effects of consuming four products through evaluation of stem cell surveillance and mitochondrial resilience. Data on stem cell trafficking will be collected. The testing will show whether consuming the products leads to a rapid change in stem cell surveillance. Data on cellular energy production and mitochondrial resilience in white blood cells under oxidative and inflammatory stress ex vivo will be collected. This testing will show whether consuming the test products leads to support of energy production within mitochondria, under normal and stressed conditions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo2 capsules
DIETARY_SUPPLEMENTChaga Mushroom2 capsules
DIETARY_SUPPLEMENTGinseng extract2 capsules
DIETARY_SUPPLEMENTOlive extract2 capsules
DIETARY_SUPPLEMENTPotassium Hydrogen Glucarate2 capsules

Timeline

Start date
2025-05-21
Primary completion
2025-08-27
Completion
2025-10-03
First posted
2025-08-17
Last updated
2025-08-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07127705. Inclusion in this directory is not an endorsement.